Geoffrey Hartzler, interventional cardiology pioneer, has died after a battle with cancer at the age of 65.
Advertisement
Latest News
-
Wednesday, May 16, 2012 | Source: EuroPCR 2012
-
By Jason Kahn
PARIS, France—Using computed tomographic (CT) imaging to calculate fractional flow reserve (FFR) enables accurate 3 D modeling of coronary stenosis…
-
Wednesday, May 16, 2012 | Source: EuroPCR 2012
-
By Caitlin E. Cox
PARIS, France—Two novel drug eluting stents (DES) with bioresorbable scaffolds made promising debuts in separate first in man studies presented at…
-
Wednesday, May 16, 2012 | Source: EuroPCR 2012
-
By Caitlin E. Cox
PARIS, France—Treating a failed bioprosthesis via transcatheter aortic valve replacement (TAVR)—the so-called valve-in-valve approach—is feasible and…
-
Wednesday, May 16, 2012 | Source: EuroPCR 2012
-
By Jason Kahn
PARIS, France—Two studies showed conflicting results on the accuracy of a new intracoronary resistance measurement that obviates the need for drug…
-
Tuesday, May 15, 2012 | Source: EuroPCR 2012
-
By Caitlin E. Cox
PARIS, France—Fractional flow reserve (FFR) measurements help identify which patients with stable coronary artery disease (CAD) cannot rely solely…
-
Tuesday, May 15, 2012 | Source: EuroPCR 2012
-
By Jason Kahn
PARIS, France—Two different biolimus A9 eluting stents, each with biodegradable abluminal coatings, showed positive results in separate randomized…
-
Monday, May 14, 2012 | Source: Journal of the American College of Cardiology
-
By Yael Maxwell
As a diagnostic tool, cardiac catheterization has become central to many a cardiologist’s practice. Yet because it is so popular, a new set of criteria…
-
Monday, May 14, 2012 | Source: Journal of the American College of Cardiology
-
By Kim Dalton
Only slightly more than one-third of percutaneous coronary interventions (PCI) among elective patients are considered appropriate, half are of uncertain…
-
Friday, May 11, 2012 | Source: Society for Cardiovascular Angiography Interventions 2012
-
By Caitlin E. Cox
Stenting of iliac artery disease in patients with severely calcified lesions or extensive peripheral artery disease (PAD)—who have historically have…
-
Friday, May 11, 2012 | Source: AHA Quality of Care and Outcomes Research 2012
-
By L.A. McKeown
Older patients with multivessel disease and baseline clinical factors including male sex and diabetes may have better long term outcomes with coronary…
News From Industry
-
Tuesday, May 15, 2012
ART receives receives regulatory approval to begin First-In-Man “ARTDIVA” clinical trial with its next-generation bioresorbable stent
-
Tuesday, May 15, 2012
One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent
-
Tuesday, May 15, 2012
Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial
-
Tuesday, May 15, 2012
Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
-
Monday, May 14, 2012
Boston Scientific Announces CE Mark and European Launch of Innova™ Self-expanding Bare-metal Stent System
|